D. Guillemot

发表

DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma

Nathan C. Sheffield, Ruth Ladenstein, Christoph Bock, 2017, Nature Medicine.

An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB‐fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts

P. Varlet, S. Puget, K. Mokhtari, 2021, Brain pathology.

A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes

P. Varlet, F. Chrétien, T. Faillot, 2021, Acta neuropathologica communications.

An extracranial CNS presentation of the emerging “intracranial” mesenchymal tumor, FET: CREB-fusion positive

P. Varlet, F. Chrétien, A. Tauziède-Espariat, 2022, Brain Tumor Pathology.

EVER2 protein binds TRADD to promote TNF- (cid:11) -induced apoptosis

Y. Jacob, G. Gaud, D. Guillemot, 2020 .

Fanconi anemia and solid malignancies in childhood: A national retrospective study

J. Soulier, D. Stoppa-Lyonnet, T. Leblanc, 2015, Pediatric blood & cancer.

Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency.

M. Daudon, B. Knebelmann, A. Bensman, 2010, Journal of the American Society of Nephrology : JASN.

The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS‐TFCP2 fusion transcript

A. Laprie, F. Le Loarer, S. Le Guellec, 2020, Pediatric blood & cancer.

The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation

P. Varlet, D. Surdez, O. Delattre, 2016, Nature Communications.

Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas

O. Delattre, Eléonore Frouin, S. Reynaud, 2021, Genes, chromosomes & cancer.

Transcriptomic definition of molecular subgroups of small round cell sarcomas

O. Delattre, F. Tirode, J. Coindre, 2018, The Journal of pathology.

Identification of tissue of origin and guided therapeutic applications in cancers of unknown primary using deep learning and RNA sequencing (TransCUPtomics).

O. Mariani, A. Vincent-Salomon, O. Delattre, 2021, The Journal of molecular diagnostics : JMD.

NTRK‐rearranged spindle cell neoplasms are ubiquitous tumours of myofibroblastic lineage with a distinct methylation class

P. Varlet, S. Puget, F. Bourdeaut, 2022, Histopathology.

CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population

M. Kool, P. Varlet, P. Chaynes, 2023, Acta Neuropathologica Communications.

BCOR immunohistochemistry, but not SATB2 immunohistochemistry, is a sensitive and specific diagnostic biomarker for central nervous system tumours with BCOR internal tandem duplication

P. Varlet, F. Chrétien, A. Tauziède-Espariat, 2021, Histopathology.

The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of “CNS tumors with BCOR internal tandem duplication”

P. Varlet, N. Boddaert, J. Grill, 2020, Acta neuropathologica communications.

Unusual primary cerebral localization of a CIC–DUX4 translocation tumor of the Ewing sarcoma family

K. Mokhtari, F. Bielle, M. Zanello, 2014, Acta Neuropathologica.

Intra‐ and extra‐cranial BCOR‐ITD tumours are separate entities within the BCOR ‐rearranged family

O. Delattre, F. Tirode, D. Orbach, 2022, The journal of pathology. Clinical research.

The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of “CNS tumors with BCOR internal tandem duplication”

P. Varlet, N. Boddaert, J. Grill, 2020, Acta Neuropathologica Communications.

CNS tumors with YWHAE:NUTM2 and KDM2B-fusions present molecular similarities to extra-CNS tumors having BCOR internal tandem duplication or alternative fusions

P. Varlet, N. Boddaert, S. Puget, 2021, Acta neuropathologica communications.

Pineal alveolar rhabdomyosarcoma with PAX3:NCOA2 fusion inducing OLIG2 expression, a potential pitfall in the central nervous system

P. Varlet, N. Boddaert, F. Chrétien, 2021, Histopathology.

CRTC1-TRIM11 Fusion in a Case of Metastatic Clear Cell Sarcoma: Are CRTC1-TRIM11 Fusion-bearing Tumors Melanocytomas or Clear Cell Sarcomas?

L. Vercellino, C. Lebbé, M. Battistella, 2019, The American journal of surgical pathology.

Loss of the HPV-Infection Resistance EVER2 Protein Impairs NF-κB Signaling Pathways in Keratinocytes

G. Gaud, F. Vuillier, M. Favre, 2014, PloS one.

CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm

P. Varlet, B. Lhermitte, D. Figarella-Branger, 2023, Acta Neuropathologica Communications.

EVER2 protein binds TRADD to promote TNF-α-induced apoptosis

Y. Jacob, G. Gaud, F. Vuillier, 2013, Cell Death and Disease.

Molecular description of meningeal solitary fibrous tumors/hemangiopericytomas compared to meningiomas: two completely separate entities

K. Mokhtari, C. Apra, Eléonore Frouin, 2021, Journal of Neuro-Oncology.

Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis

O. Delattre, H. Brisse, B. Geoerger, 2023, Expert review of anticancer therapy.

Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.

D. Surdez, C. Chauvin, C. Pouponnot, 2023, Nature communications.

Fanconi anemia and solid malignancies in childhood: A national retrospective study

J. Soulier, D. Stoppa-Lyonnet, T. Leblanc, 2015, Pediatric Blood & Cancer.

Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency.

M. Daudon, B. Knebelmann, A. Bensman, 2010, Journal of the American Society of Nephrology : JASN.